Up 12% on news that the FDA will review the resubmission.
After being up 80% on news that the FDA will accept a resubmission and review it.
A resubmission for approval for the third time.
None of this is unexpected or surprising. And the verdict is still just as uncertain as it always has been.
I would be wary buying at these prices, as it seems to be very hype driven. It's absolutely not driven by fundamentals at this point.
IMO, DYOR.
Fingers crossed third time is the charm
- Forums
- ASX - By Stock
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Up 12% on news that the FDA will review the resubmission.After...
-
-
- There are more pages in this discussion • 206 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
98.5¢ |
Change
0.015(1.55%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
96.5¢ | 99.5¢ | 96.5¢ | $1.394M | 1.425M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 45471 | 98.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.5¢ | 47052 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 57054 | 0.975 |
15 | 98103 | 0.970 |
14 | 183456 | 0.965 |
15 | 142860 | 0.960 |
9 | 509682 | 0.955 |
Price($) | Vol. | No. |
---|---|---|
0.980 | 46803 | 33 |
0.985 | 100977 | 16 |
0.990 | 154993 | 20 |
0.995 | 191537 | 11 |
1.000 | 135535 | 13 |
Last trade - 12.52pm 26/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |